At UCB, we approach clinical studies by engaging patients to understand what is most important to them. Our Medical Writing Specialist, Joy Avery, is able to tap into her experience as a patient herself in order to help UCB focus on what patients value. Read more from Joy about why she puts patients at the heart of everything she does.

At UCB, it’s about the patient and doing what the patient values, which we believe is having their best life possible. Our Senior Director, External Innovation Lead, Dr. Miguel Camargo came to UCB because he felt we were was serious about that mission and that he could make an impact through discovering medicine. Read more from Dr. Camargo about why he puts patients at the heart of everything he does.

UCB is pleased to announce 38 recipients were awarded the 2019 UCB Family Epilepsy Scholarship. This year’s UCB Family Epilepsy Scholarship program includes six additional awards. We awarded a $10,000 Joe D’Souza Memorial Scholarship along with five additional $5,000 scholarships for 2019.

At UCB, we go beyond just treating a person or their symptoms, it’s about seeing the person as a whole – from their emotional to physical well-being – and finding solutions that improve their care and overall quality of life. Read more from our VP of U.S. Corporate Affairs, Patty Fritz, about why she puts patients are at the heart of everything she does.

We’re proud our employees are as diverse as the patients we serve – from what drives them each day to their own personal experiences that shape who they are. At UCB, we believe by encouraging our employees to channel their energy, passions, and different perspectives, we can better understand and rethink how we innovate and deliver impactful solutions patients value. Join us as we begin a 5-part series showcasing what drives UCB employees to put patients at the heart of everything they do.

UCB is collaborating with DEARhealth, Inc. to improve care delivery for people living with epilepsy. More than 1 in 26 Americans will experience epilepsy at some point in their lives, and many also suffer from stigma around their condition.

UCB is in San Diego for DIA-Global 2019 this week. Ahead of her presentation, Liz Roberts, our Global Public Policy Lead, shares insights from the industry perspective on clinical trial disclosure and data transparency, and what UCB is doing to keep patients at the center of our work in this space. For more, see Liz speak today, June 25, 2019 at 2:00 p.m. in room 4 (session #260).

From discovery to development to delivery, how we do business has been transformed and redesigned around the patient’s individual experience. At UCB, patients are at the heart of everything we do, inspiring us and driving the ways in which we research, develop, and study differentiated treatments for patients. For 18 years, UCB BioSciences has been in the Research Triangle Park (RTP) in North Carolina and is an integral part of UCB’s mission to bring differentiated medicines to patients.

At UCB, how we do science – from discovery to development to delivery – has been transformed and redesigned around understanding the patient and their individual experience. For specific patient populations new to UCB – like Myasthenia gravis (MG) – this is especially important because no two experiences of this rare, neuromuscular condition are alike. In honor of Myasthenia Gravis Awareness Month, join us as we shine a spotlight to help spread awareness and empower people living with MG.

Every day, UCB researchers come to work driven by a singular purpose – to create value for people living with severe disease. That’s because, across the world, patients depend on the important work of scientific research to find new medical innovations that will help them achieve their goals. From the “breakthrough” moments in discovery, development, and delivery, we are dedicated to finding solutions for the unmet needs of patients.